KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) EBIT (2016 - 2025)

Historic EBIT for Global Medical REIT (GMRE) over the last 10 years, with Q3 2025 value amounting to -$7.3 million.

  • Global Medical REIT's EBIT fell 2373.49% to -$7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.5 million, marking a year-over-year decrease of 3316.37%. This contributed to the annual value of -$25.0 million for FY2024, which is 1904.94% down from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's EBIT is -$7.3 million, which was down 2373.49% from -$7.8 million recorded in Q2 2025.
  • Global Medical REIT's 5-year EBIT high stood at $1.4 million for Q3 2021, and its period low was -$8.3 million during Q4 2024.
  • Moreover, its 5-year median value for EBIT was -$5.1 million (2024), whereas its average is -$4.0 million.
  • As far as peak fluctuations go, Global Medical REIT's EBIT skyrocketed by 22966.87% in 2021, and later tumbled by 489056.6% in 2022.
  • Over the past 5 years, Global Medical REIT's EBIT (Quarter) stood at -$106000.0 in 2021, then tumbled by 4890.57% to -$5.3 million in 2022, then rose by 11.64% to -$4.7 million in 2023, then plummeted by 77.69% to -$8.3 million in 2024, then rose by 12.56% to -$7.3 million in 2025.
  • Its EBIT stands at -$7.3 million for Q3 2025, versus -$7.8 million for Q2 2025 and -$5.2 million for Q1 2025.